In 2022, darolutamide was FDA-approved in combination with docetaxel chemotherapy for adults with metastatic hormone-sensitive prostate cancer
The companies plan to start a pivotal Phase 3 trial in the coming months
The company expects that this development could improve the strength of its application to the FDA for new drug approval
LG Chem is making progress in the development of the world's first oral treatment for rare forms of obesity.
Short-term treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD)
Profit after tax (before exceptional items) up 23% to Rs 215 crores
Glenmark's current portfolio consists of 188 products authorized for distribution in the US
Lupin enters into BTA with Lupin Manufacturing Solutions
PFA technology is only marketed in Europe, and yet, it has been dominating the electrophysiology market by storm
Tagrisso is projected to be a pivotal contributor to AstraZeneca’s portfolio
Subscribe To Our Newsletter & Stay Updated
